Investment analysts at Needham & Company boosted their target price on shares of Plexus (NASDAQ: PLXS)
Plexus traded down 0.12% on Friday, hitting $26.05. Plexus has a 52-week low of $19.63 and a 52-week high of $38.37. The stock?s 50-day moving average is currently $24.47. The company has a market cap of $907.6 million and a price-to-earnings ratio of 15.24.
Plexus last announced its earnings results on Wednesday, January 16th. The company reported $0.47 earnings per share for the quarter, missing the analysts? consensus estimate of $0.48 by $0.01. The company had revenue of $530.50 million for the quarter, compared to the consensus estimate of $551.98 million. During the same quarter in 2012, the company posted $0.51 earnings per share. Plexus?s revenue was up .2% compared to the same quarter last year. Plexus has set its Q2 guidance at $0.50-0.55 EPS. On average, analysts predict that Plexus will post $2.01 earnings per share for the current fiscal year.
PLXS has been the subject of a number of other recent research reports. Analysts at Bank of America upgraded shares of Plexus to a ?neutral? rating in a research note to investors on Monday, December 24th. Finally, analysts at RBC Capital cut their price target on shares of Plexus from $31.00 to $24.00 in a research note to investors on Thursday, November 8th. They now have a ?sector perform? rating on the stock.
Two investment analysts have rated the stock with a buy rating, eight have issued a hold rating, and one has assigned a sell rating to the company. The stock has a consensus rating of ?hold? and a consensus target price of $23.64.
Plexus Corp. (Plexus), along with its subsidiaries, provide optimized product realization solutions through a product realization value stream service model.